These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16607148)

  • 1. Does alpha1-antitrypsin phenotype PiMZ increase the risk of fibrosis in liver disease due to hepatitis C virus infection?
    Scott BB; Egner W
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):521-3. PubMed ID: 16607148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
    Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP
    Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of children with α-1 antitrypsin deficiency.
    Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis.
    Cacciottolo TM; Gelson WT; Maguire G; Davies SE; Griffiths WJ
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):412-7. PubMed ID: 24518491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease.
    Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W
    Ann Intern Med; 1992 Oct; 117(8):641-5. PubMed ID: 1530195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.
    Serfaty L; Chazouillères O; Poujol-Robert A; Morand-Joubert L; Dubois C; Chrétien Y; Poupon RE; Petit JC; Poupon R
    Hepatology; 1997 Sep; 26(3):776-9. PubMed ID: 9303512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
    Banner BF; Karamitsios N; Smith L; Bonkovsky HL
    Am J Gastroenterol; 1998 Sep; 93(9):1541-5. PubMed ID: 9732941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].
    Manekeller S; Sauerbruch T; Fischer HP; Propping P; Hirner A
    Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease.
    Eigenbrodt ML; McCashland TM; Dy RM; Clark J; Galati J
    Am J Gastroenterol; 1997 Apr; 92(4):602-7. PubMed ID: 9128307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine protease inhibitors in patients with chronic viral hepatitis.
    Elzouki AN; Verbaan H; Lindgren S; Widell A; Carlson J; Eriksson S
    J Hepatol; 1997 Jul; 27(1):42-8. PubMed ID: 9252072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ.
    Seersholm N; Wilcke JT; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 2000 Jan; 161(1):81-4. PubMed ID: 10619801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.
    Sartori M; Andorno S; Pagliarulo M; Rigamonti C; Bozzola C; Pergolini P; Rolla R; Suno A; Boldorini R; Bellomo G; Albano E
    Gut; 2007 May; 56(5):693-8. PubMed ID: 17135308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.
    Şımşek H; Pinar A; Altinbaş A; Alp A; Balaban YH; Büyükaşik Y; Özcebe O; Hasçelık G; Gedıkoğlu G; Tatar G
    Turk J Gastroenterol; 2012; 23(5):569-73. PubMed ID: 23161303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiency.
    Hilsden RJ; Urbanski SJ; Swain MG
    Arthritis Rheum; 1995 Jul; 38(7):1014-8. PubMed ID: 7612033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
    Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver disease and heterozygous alpha-1-antitrypsin deficiency.
    Pittschieler K
    Acta Paediatr Scand; 1991 Mar; 80(3):323-7. PubMed ID: 2035327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [alpha 1-Antitrypsin phenotypes in patients with chronic liver diseases].
    Pott G; Schneider M; van Husen N; von Bassewitz DB; Eberhardt G; Gerlach U
    Z Gastroenterol; 1983 Jul; 21(7):318-23. PubMed ID: 6604375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.